Visa is making its biggest security play in years. The payments giant plans to acquire BioCatch, a behavioral biometrics company specializing in fraud detection, in a deal reportedly valued between $2B and $2.4B in cash.
BioCatch announced the planned acquisition on LinkedIn on August 3. For a company that was valued at $1.3B just two years ago when Permira Growth Opportunities took a majority stake, that’s a near-doubling in valuation. Not a bad return for Permira’s roughly 22-month holding period.
What BioCatch actually does
Think of BioCatch as a digital body language reader. Instead of relying solely on passwords or two-factor authentication, the company’s technology analyzes how users physically interact with their devices. The way you swipe, type, hold your phone, even pause between actions creates a behavioral fingerprint that’s extremely difficult for fraudsters to replicate.
The numbers behind this tech are staggering. In 2025 alone, BioCatch’s platform analyzed $17.2T in transactions, roughly equivalent to about 70% of US GDP flowing through its behavioral analysis engine in a single year. That same year, the company helped prevent $4B in fraudulent activity.
Over 350 banks globally currently use BioCatch’s solutions, and the company claims its technology protects more than 1.7 billion devices worldwide. Those are the kind of metrics that make a $2B+ price tag look reasonable rather than aspirational.
Why Visa is writing this check now
For Visa, the acquisition also serves a competitive purpose. Mastercard, PayPal, and a growing roster of fintech challengers are all investing heavily in security infrastructure. Owning BioCatch outright, rather than partnering with the company, gives Visa a proprietary layer of fraud prevention that competitors can’t simply license for themselves.
As real-time payment systems expand globally, the window for catching fraud shrinks dramatically. You can’t claw back an instant payment the way you can reverse a credit card charge. BioCatch’s real-time behavioral analysis is built precisely for this faster, more unforgiving payments landscape.
What this means for the broader market
For investors tracking the cybersecurity-meets-fintech intersection, this deal reprices expectations across the sector. BioCatch’s jump from a $1.3B valuation in September 2024 to a reported $2B to $2.4B exit suggests that acquirers are willing to pay steep premiums for companies with proven fraud prevention at scale.
The deal still awaits formal confirmation of terms and regulatory approval. But if it closes at the reported range, it will stand as one of the largest pure-play fraud prevention acquisitions in fintech history.